Skip to main content

Table 2 Participants with consultation and decision characteristics

From: Investigating active ingredients in a complex intervention: a nested study within the Patient and Decision Aids (PANDAs) randomised controlled trial for people with type 2 diabetes

Patient

Gender

Control preference (pre-consultation)

Clinician

Consultation (minutes)

OPTION score

Decision

Control preference (post-consultation)

Decision conflict (post-consultation)

A

f

collaborative

PN

20

31

Add insulin

autonomous

0.00

B

f

collaborative

GP

13

15

Current advice*

collaborative

12.50

C

f

autonomous

GP

4

10

Current advice*

autonomous

0.00

D

m

autonomous

PN

17

30

Current advice*

autonomous

25.00

E

m

passive

PN

17

27

Current advice*

autonomous

9.38

F

m

autonomous

PN

29

28

Not sure

autonomous

0.00

G

m

passive

PN

16

34

Make no change

collaborative

25.00

H

m

collaborative

GP

7

15

Add insulin

autonomous

0.00

  1. Notes: PN = Practice Nurse, GP = General Practitioner; OPTION (Observing Patient Involvement) score based on 12 item measure, scores range 0 to 48, higher score indicate greater patient involvement in decision taking. *Follow advice about current diabetes therapies (oral medication/lifestyle) more regularly. Decision conflict scores: range = 0–100; low score is better; score below 25 associated with implementing decisions; score above 37.5 associated with decisional delay.